Dendritic cell-based cancer vaccination:quo vadis?

Effect of Melanoma on Immune Function in the Regional Lymph Node Basin

(2008) B. Negin et al.   CLINICAL CANCER RESEARCH

CD40 ligation during dendritic cell maturation reduces cell death and prevents interleukin-10-induced regression to macrophage-like monocytes

(2008) Holger Haenssle et al.   EXPERIMENTAL DERMATOLOGY

Therapeutic vaccines in cancer: moving from immunomonitoring to immunoguiding

(2008) Sjoerd H van der Burg   Expert Review of Vaccines

Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape

(2008) Jessica B. Katz et al.   IMMUNOLOGICAL REVIEWS

The cell biology of cross-presentation and the role of dendritic cell subsets

(2008) Ming-Lee Lin et al.   IMMUNOLOGY AND CELL BIOLOGY

Combined use of toll-like receptor agonists and prostaglandin E2 in the FastDC model: Rapid generation of human monocyte-derived dendritic cells capable of migration and IL-12p70 production

(2008) Marc Dauer et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Chemotherapeutic Drugs may be Used to Enhance the Killing Efficacy of Human Tumor Antigen Peptide-specific CTLs

(2008) Pierpaolo Correale et al.   JOURNAL OF IMMUNOTHERAPY

Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA

(2008) Aude Bonehill et al.   MOLECULAR THERAPY